The Board of Prima Biomed Ltd. announced that Marc Voigt has been appointed as Chief Executive Officer of Prima. Mr. Voigt, Prima's Chief Business Officer and Chief Financial Officer as well as General Manager of the company's European Operations, replaces US based Matthew Lehman who will step down from the Board but remain as an adviser to the company to facilitate an orderly transition. Following his appointment as CEO, Marc Voigt will join the Prima Board as an Executive Director.

Marc has more than 16 years of experience in the financial and biotech industry, having joined the Prima team in 2011 as the General Manager, European Operations based in Berlin, Germany.